474 related articles for article (PubMed ID: 35216586)
1. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
3. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
6. [Health economic evaluation of telemedicine diabetic retinopathy examination using a non-mydriatic fundus camera in China].
Fan JX; Zhang M; Zhao WY; Han Y; Hu WT; Jia HX; Sun XD
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):919-929. PubMed ID: 37936360
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of AI-assisted screening for diabetic retinopathy in rural areas of midwest China.
Hao S; Liu C; Li N; Wu Y; Li D; Gao Q; Yuan Z; Li G; Li H; Yang J; Fan S
PLoS One; 2022; 17(10):e0275983. PubMed ID: 36227905
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
Gomez Rossi J; Rojas-Perilla N; Krois J; Schwendicke F
JAMA Netw Open; 2022 Mar; 5(3):e220269. PubMed ID: 35289862
[TBL] [Abstract][Full Text] [Related]
10. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study.
Ming S; Xie K; Lei X; Yang Y; Zhao Z; Li S; Jin X; Lei B
Int Ophthalmol; 2021 Apr; 41(4):1291-1299. PubMed ID: 33389425
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
Wolf RM; Channa R; Abramoff MD; Lehmann HP
JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
[TBL] [Abstract][Full Text] [Related]
13. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Screen for Diabetic Retinopathy in Chinese Patients with Newly Diagnosed Type 2 Diabetes: A Cost-Effectiveness Analysis.
Wu B; Li J; Wu H
Medicine (Baltimore); 2015 Nov; 94(45):e1989. PubMed ID: 26559285
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 21 artificial intelligence algorithms in automated diabetic retinopathy screening using handheld fundus camera.
Kubin AM; Huhtinen P; Ohtonen P; Keskitalo A; Wirkkala J; Hautala N
Ann Med; 2024 Dec; 56(1):2352018. PubMed ID: 38738798
[TBL] [Abstract][Full Text] [Related]
16. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
Xiao X; Xue L; Ye L; Li H; He Y
BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
[TBL] [Abstract][Full Text] [Related]
17. [Using artificial intelligence as an initial triage strategy in diabetic retinopathy screening program in China].
Li ZX; Zhang J; Fong N; He MG
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(48):3835-3840. PubMed ID: 33371627
[No Abstract] [Full Text] [Related]
18. Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study.
Kawasaki R; Akune Y; Hiratsuka Y; Fukuhara S; Yamada M
Ophthalmic Epidemiol; 2015 Feb; 22(1):4-12. PubMed ID: 25517603
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness Analysis of a Personalized, Teleretinal-Inclusive Screening Policy for Diabetic Retinopathy via Markov Modeling.
Dorali P; Shahmoradi Z; Weng CY; Lee T
Ophthalmol Retina; 2023 Jun; 7(6):532-542. PubMed ID: 36621610
[TBL] [Abstract][Full Text] [Related]
20. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
van Katwyk S; Jin YP; Trope GE; Buys Y; Masucci L; Wedge R; Flanagan J; Brent MH; El-Defrawy S; Tu HA; Thavorn K
Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
